Insight Molecular Diagnostics Inc. Joins JPM Week and BTIG Snowbird Investor Conferences

Reuters
01/08
<a href="https://laohu8.com/S/IMDX">Insight Molecular Diagnostics Inc.</a> Joins <a href="https://laohu8.com/S/JPM">JPM</a> Week and BTIG Snowbird Investor Conferences

Insight Molecular Diagnostics Inc. (iMDx) will participate in several investor conferences this winter. The company’s management team will hold one-on-one meetings at the LifeSci Advisors 15th Annual Corporate Access Event on January 12 in San Francisco, as well as additional investor meetings in San Francisco from January 12 to January 14 during "JPM Week." iMDx will also attend the BTIG 13th Annual Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference, taking place from February 9 to 11 at Cliff Lodge in Snowbird, Utah.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insight Molecular Diagnostics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9621595) on January 07, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10